Anviron
Targeting the Cancer Glycobiome
We are a team of passionate scientists, doctors and clinicians, driven to fight late stage cancers.
ABOUT ANVIRON
About our company, our mission and our team.
OUR PIPELINE
Overview of our pipeline and our science
LATEST NEWS
Latest news releases and investor packages
We are a growing team of scientists, clinicians, and physicians focused on developing promising therapies for difficult to treat diseases. Join a team that is committed to discovering and providing good medicines that make a difference in peoples lives.
JOIN OUR TEAM
COMMUNICATIONS
Get regular updates on our company and pipeline
OUR DRUG PIPELINE
Our pipeline consists of a promising family of small molecules inhibitors of proteins responsible for unconstrained proliferation signaling and metastasis.
ANV221 for Pancreatic Cancer
A novel product candidate shown to reduce pancreatic cancer tumor size and suppress metastases (in vivo models) superior to approved standard of care drugs in vivo models.
